A Second RNA-Binding Site in the NS1 Protein of Influenza B Virus

Slides:



Advertisements
Similar presentations
Volume 22, Issue 4, Pages (April 2014)
Advertisements

Ross Alexander Robinson, Xin Lu, Edith Yvonne Jones, Christian Siebold 
Volume 22, Issue 2, Pages (February 2014)
Volume 23, Issue 11, Pages (November 2015)
Volume 13, Issue 7, Pages (July 2005)
Volume 17, Issue 11, Pages (November 2009)
Shiqing Li, Paul Kussie, Kathryn M. Ferguson  Structure 
Volume 14, Issue 9, Pages (September 2006)
Identification of Phe187 as a Crucial Dimerization Determinant Facilitates Crystallization of a Monomeric Retroviral Integrase Core Domain  Meytal Galilee,
Volume 15, Issue 12, Pages (December 2007)
Chaperone-Assisted Crystallography with DARPins
Volume 108, Issue 6, Pages (March 2002)
Volume 18, Issue 8, Pages (August 2010)
Volume 23, Issue 7, Pages (July 2015)
Volume 22, Issue 1, Pages (January 2014)
Structure of the Angiopoietin-2 Receptor Binding Domain and Identification of Surfaces Involved in Tie2 Recognition  William A. Barton, Dorothea Tzvetkova,
Volume 36, Issue 4, Pages (November 2009)
HyeongJun Kim, Jen Hsin, Yanxin Liu, Paul R. Selvin, Klaus Schulten 
Volume 19, Issue 3, Pages (March 2011)
Structure and RNA Interactions of the N-Terminal RRM Domains of PTB
Phospho-Pon Binding-Mediated Fine-Tuning of Plk1 Activity
Nadine Keller, Jiří Mareš, Oliver Zerbe, Markus G. Grütter  Structure 
A Solution to Limited Genomic Capacity: Using Adaptable Binding Surfaces to Assemble the Functional HIV Rev Oligomer on RNA  Matthew D. Daugherty, Iván.
Solution and Crystal Structures of a Sugar Binding Site Mutant of Cyanovirin-N: No Evidence of Domain Swapping  Elena Matei, William Furey, Angela M.
Ross Alexander Robinson, Xin Lu, Edith Yvonne Jones, Christian Siebold 
Crystal Structures of RNase H Bound to an RNA/DNA Hybrid: Substrate Specificity and Metal-Dependent Catalysis  Marcin Nowotny, Sergei A. Gaidamakov, Robert.
Volume 21, Issue 10, Pages (October 2013)
Volume 23, Issue 6, Pages (December 2005)
Volume 20, Issue 1, Pages 9-19 (October 2005)
Volume 21, Issue 8, Pages (August 2013)
Volume 18, Issue 8, Pages (August 2010)
Volume 18, Issue 6, Pages (June 2010)
Volume 21, Issue 6, Pages (June 2013)
The Structure of the Tiam1 PDZ Domain/ Phospho-Syndecan1 Complex Reveals a Ligand Conformation that Modulates Protein Dynamics  Xu Liu, Tyson R. Shepherd,
Volume 13, Issue 2, Pages (February 2005)
Structural Diversity in Integrin/Talin Interactions
Volume 19, Issue 9, Pages (September 2011)
A Second RNA-Binding Site in the NS1 Protein of Influenza B Virus
Volume 20, Issue 7, Pages (July 2012)
Volume 12, Issue 7, Pages (July 2004)
Mark Del Campo, Alan M. Lambowitz  Molecular Cell 
Volume 19, Issue 1, Pages (January 2011)
Volume 18, Issue 8, Pages (August 2010)
A Putative Mechanism for Downregulation of the Catalytic Activity of the EGF Receptor via Direct Contact between Its Kinase and C-Terminal Domains  Meytal.
Volume 11, Issue 2, Pages (February 2003)
Size Selective Recognition of siRNA by an RNA Silencing Suppressor
Crystal Structures of the BAR-PH and PTB Domains of Human APPL1
Meigang Gu, Kanagalaghatta R. Rajashankar, Christopher D. Lima 
Volume 19, Issue 7, Pages (July 2011)
A Second RNA-Binding Site in the NS1 Protein of Influenza B Virus
Volume 12, Issue 1, Pages (July 2015)
Structure of the Staphylococcus aureus AgrA LytTR Domain Bound to DNA Reveals a Beta Fold with an Unusual Mode of Binding  David J. Sidote, Christopher.
Volume 19, Issue 7, Pages (July 2011)
Crystal Structures of RNase H Bound to an RNA/DNA Hybrid: Substrate Specificity and Metal-Dependent Catalysis  Marcin Nowotny, Sergei A. Gaidamakov, Robert.
Volume 19, Issue 8, Pages (August 2011)
Volume 13, Issue 5, Pages (May 2005)
Volume 27, Issue 7, Pages e5 (July 2019)
The AXH Domain Adopts Alternative Folds
Caroline M. Groft, Stephen K. Burley  Molecular Cell 
Volume 25, Issue 9, Pages e3 (September 2017)
Matthieu Chavent, Elena Seiradake, E. Yvonne Jones, Mark S.P. Sansom 
Structure and Dimerization of a Soluble Form of B7-1
A Plug Release Mechanism for Membrane Permeation by MLKL
Volume 126, Issue 4, Pages (August 2006)
The Structure of T. aquaticus DNA Polymerase III Is Distinct from Eukaryotic Replicative DNA Polymerases  Scott Bailey, Richard A. Wing, Thomas A. Steitz 
Structural Basis for Ligand Recognition and Activation of RAGE
Structure of GABARAP in Two Conformations
Structure of the Mtb CarD/RNAP β-Lobes Complex Reveals the Molecular Basis of Interaction and Presents a Distinct DNA-Binding Domain for Mtb CarD  Gulcin.
The Structure of the MAP2K MEK6 Reveals an Autoinhibitory Dimer
The Human Cytomegalovirus UL44 C Clamp Wraps around DNA
Presentation transcript:

A Second RNA-Binding Site in the NS1 Protein of Influenza B Virus Li-Chung Ma, Rongjin Guan, Keith Hamilton, James M. Aramini, Lei Mao, Shanshan Wang, Robert M. Krug, Gaetano T. Montelione  Structure  Volume 24, Issue 9, Pages 1562-1572 (September 2016) DOI: 10.1016/j.str.2016.07.001 Copyright © 2016 Elsevier Ltd Terms and Conditions

Figure 1 The X-Ray Crystal Structure of the CTD of NS1B Protein Reveals a Broad Basic Surface (A) Ribbon diagram showing the 2.0-Å X-ray crystal structure of the dimeric NS1B CTD. β strands are numbered 1–7, α helices α1–α3, and 310 helices as η1–η2. (B) The electrostatic surface of the NS1B CTD calculated with the APBS plugin (Baker et al., 2001) of PyMOL (DeLano, 2002) at ± 5 kT/e (red, negative; blue, positive). (C) The structure of NS1B CTD (magenta) superimposed on the structure of NS1A CTD (green, PDB: 3EE9) (Xia and Robertus, 2010). (D) 15N-1H chemical shift perturbations Δδcomp due to dsRNA binding mapped onto the 3D structure of the NS1B CTD. Residues with backbone 15N-1H chemical shift perturbations due to dsRNA binding Δδcomp ≤ 20 ppb, 20 < Δδcomp < 30 ppb, and Δδcomp ≥ 30 ppb are highlighted in gray, light blue, and dark blue, respectively (see Figure S2). Residues for which chemical shift perturbations could not be determined, including Pro residues, are shown in white. The molecular orientations in (A), (B), (C), and (D, left) are the same. (D) also shows an orientation rotated by 180°, revealing no significant chemical shift perturbations on the opposite side of the molecule. Structure 2016 24, 1562-1572DOI: (10.1016/j.str.2016.07.001) Copyright © 2016 Elsevier Ltd Terms and Conditions

Figure 2 Fluorescence Polarization Assays of Nucleic Acid Binding Activity FP, in units of millipolarization (mP), resulting from binding of fluorescein-labeled DNA and RNA molecules to NS1B CTD. (A) Binding of poly(A)16 ssRNA (A16, red) versus poly(dA16) ssDNA (dA16, black). (B) Binding of poly(A)16 ssRNA (A16, blue), minus strand of a 16-nt ssRNA (16 minus, red), and 16-bp dsRNA (16 bp, black). (C and D) The effects of alanine replacements of individual Lys and Arg residues on the (C) ssRNA- and (D) dsRNA-binding activity of NS1B CTD, assayed by FP. The yellow histogram bar in each plot designates data for dimer-disrupting mutant R238A at the protein-protein interface formed at high protein concentrations and observed in the X-ray crystal structure. Error bars represent the SD of triplicate measurements. Structure 2016 24, 1562-1572DOI: (10.1016/j.str.2016.07.001) Copyright © 2016 Elsevier Ltd Terms and Conditions

Figure 3 NMR Studies Demonstrate that the Dimer Interface in Solution Is the Same as in the X-Ray Crystal Structure (A) Plot of rotational correlation times, τc (ns), obtained from 1D 15N T1/T2 relaxation data versus protein molecular weight (kDa) for WT NS1B CTD (blue), interfacial mutants [R238A]- and [R246A]-NS1B CTD (green), and monomeric proteins of known molecular weight and oligomerization state. (B) Plot of rotational correlation times, τc (ns), obtained from 1D 15N T1/T2 relaxation data at different protein concentrations of NS1B CTD, providing an estimate the self-dissociation equilibrium constant Kd ∼ 700 μM. (C) The homodimer structure of NS1B CTD determined by X-ray crystallography, highlighting key Arg238-Glu249 and Arg246-Glu168 interchain salt bridges (dashed lines) between Arg (yellow with blue N atoms) and Glu (green with red O atoms) residues. (D) Backbone amide 15N-1H chemical shift differences between WT NS1B CTD dimer and its R238A mutant monomer mapped onto the X-ray crystal structure of NS1B CTD dimer. Residues are colored as follows: blue, Δδcomp > 50 ppb; magenta, Δδcomp < 50 ppb. The side chains of residue Arg-238, mutated to Ala to form a monomer, are shown in yellow. The protein-protein interface of the weak homodimer that is formed in solution at high (>1 mM) protein concentrations is the same as that observed in the crystal (Figure 1A). All data were obtained on a Bruker 600 MHz spectrometer at 298 K. Structure 2016 24, 1562-1572DOI: (10.1016/j.str.2016.07.001) Copyright © 2016 Elsevier Ltd Terms and Conditions

Figure 4 The RNA-Binding Activity of the RNA-Binding Epitope in the C-Terminal Domain of NS1B Is Required for Influenza B Virus Replication (A and B) The data of Figures 2C and 2D are mapped onto the 3D structure of the NS1B ED dimer, shown in both (A) space-filling and (B) ball-and-stick representations, revealing the pattern of surface basic residues contributing to RNA binding (highlighted in green) and those surface basic residues that apparently do not participate in RNA binding (highlighted in yellow). (C) Growth curves of WT, R156A, K160A, and R208A mutant viruses in A549 cells infected with a low MOI, 0.1 pfu/cell. (D) Growth curves of WT and K167A mutant viruses in A549 cells infected with 0.1 pfu/cell. Error bars show the SD of triplicate assays of virus titers at the indicated times of infection determined by plaque assays in MDCK cells. Structure 2016 24, 1562-1572DOI: (10.1016/j.str.2016.07.001) Copyright © 2016 Elsevier Ltd Terms and Conditions

Figure 5 Recombinant Influenza B Viruses with Mutations in the CTD RNA-Binding Domain of NS1 All Inhibit IRF3 Activation A549 cells were infected with 5 pfu/cell of WT influenza B virus, a mutant virus encoding the N-terminal 104 amino acids of the NS1 protein, or a mutant virus expressing an NS1 protein with one of the indicated mutations in the NS1 protein. At the indicated times after infection (hr pi), cell extracts were immunoblotted with antibodies against activated (phosphorylated) IRF3 (Cell Signaling Technology), total IRF3, actin, viral NS1, or M1 protein. Structure 2016 24, 1562-1572DOI: (10.1016/j.str.2016.07.001) Copyright © 2016 Elsevier Ltd Terms and Conditions

Figure 6 A Recombinant Influenza B Virus with a R246A NS1B Mutation that Suppresses CTD Homodimerization Is Attenuated in Viral Replication (A) Growth curves of WT and R246A mutant viruses in A549 cells infected with 0.1 pfu/cell. (B) A549 cells were infected with 5 pfu/cell of WT or R246A mutant virus, and at the indicated times after infection (hr pi), cell extracts were assayed by immunoblots for activated (phosphorylated) IRF3, total IRF3, and NS1B levels, as described in the legend of Figure 5. Structure 2016 24, 1562-1572DOI: (10.1016/j.str.2016.07.001) Copyright © 2016 Elsevier Ltd Terms and Conditions

Figure 7 NS1A Proteins from Influenza A Viruses Do Not Share Conserved Surface Features that Form and RNA-Binding Surface of NS1B Proteins from Influenza B Viruses (A) A structure-based sequence alignment of the CTD domains of NS1 from influenza A and influenza B strains. Basic residues of the NS1B CTD that affect RNA binding activity when mutated to Ala are indicated with green dots. (B) Comparison of protomer orientations in the X-ray crystal structure of NS1B CTD and in one of the published X-ray crystal structures (PDB: 3EE) (Xia and Robertus, 2010) of the NS1A CTD. (C) The same dimer structure of the NS1A CTD (PDB: 3EE) (Xia and Robertus, 2010), which has been confirmed in solution by NMR studies (Aramini et al., 2014; Aramini et al., 2011), with electrostatic surface calculated with APBS (Baker et al., 2001) plugin of PyMOL (DeLano, 2002) at ± 5 kT/e (left, same orientation as illustrated by the ribbon diagram inset; right, rotated by 180°). The structure of NS1A C-terminal domain does not include a basic surface needed to support RNA binding. Error bars show the SD of triplicate assays of virus titers at the indicated times of infection determined by plaque assays in MDCK cells. All points in (A) have error bars, although some are quite small. Structure 2016 24, 1562-1572DOI: (10.1016/j.str.2016.07.001) Copyright © 2016 Elsevier Ltd Terms and Conditions

Structure 2016 24, 1562-1572DOI: (10.1016/j.str.2016.07.001) Copyright © 2016 Elsevier Ltd Terms and Conditions